Skip to main content

Advertisement

Log in

The association between endothelial lipase −384A/C gene polymorphism and acute coronary syndrome in a Chinese population

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Endothelial lipase (EL) is a novel member of the triglyceride (TG) lipase family. A growing body of evidence has indicated that EL gene polymorphism might contribute to the process of cardiovascular diseases. This study was aimed to reveal the potential relationship between EL −384A/C gene polymorphism and acute coronary syndrome (ACS) in a Chinese Han population. The subjects were composed of 320 ACS patients and 315 age- and gender- matched controls. We detected the EL −384A/C genotypes and allele frequencies by using polymerase chain reaction-restriction fragment length polymorphism analysis. There was significant difference in AA genotype and AC+CC genotype between ACS and control groups (P = 0.014). The A allele frequency was significantly higher in ACS group than in control group (87.8 vs 83.8 %, P = 0.041). The relationship between the variant and ACS remained significant after adjusting for current smoker, hypertension, diabetes mellitus, total cholesterol and TG (OR = 0.682, 95 % CI = 0.472–0.986). The levels of HDL and ApoA-I were significantly higher in AC+CC genotype than in AA genotype (HDL: 1.20 ± 0.35 vs 1.11 ± 0.29 mmol/L, P = 0.001; ApoA-I: 1.14 ± 0.25 vs 1.08 ± 0.21 g/L, P = 0.009). We found that the EL −384A/C gene polymorphism might be associated with ACS in Chinese Han population, suggesting that the variant might be involved in the pathogenesis of ACS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

ACS:

Acute coronary syndrome

CAD:

Coronary artery disease

LDL:

Low density lipoprotein

HDL:

High density lipoprotein

TG:

Triglyceride

LPL:

Lipoprotein lipase

HL:

Hepatic lipase

CVD:

Cardiovascular disease

BP:

Blood pressure

PCR–RFLP:

Polymerase chain reaction–restriction fragment length polymorphism analysis

SPSS:

Statistical package for the social sciences

SNPs:

Single-nucleotide polymorphisms

Apo:

Apolipoprotein

TC:

Total cholesterol

LP(a):

Lipoprotein(a)

AS:

Atherosclerosis

References

  1. Achari V, Thakur AK (2004) Association of major modifiable risk factors among patients with coronary artery disease: a retrospective analysis. J Assoc Physicians India 52:103–108

    PubMed  CAS  Google Scholar 

  2. Maron DJ (2000) The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease. Am J Cardiol 86(12A):11–14

    Article  Google Scholar 

  3. Saedi M, Vaisi-Raygani A, Khaghani S, Shariftabrizi A, Rezaie M, Pasalar P, Rahimi Z, Pourmotabbed T (2012) Matrix metalloproteinas-9 functional promoter polymorphism 1562C > T increased risk of early-onset coronary artery disease. Mol Biol Rep 39:555–562

    Article  PubMed  CAS  Google Scholar 

  4. Zhou X, Chen J, Xu W (2012) Association between C1431T polymorphism in peroxisome proliferator-activated receptor-gamma gene and coronary artery disease in Chinese Han population. Mol Biol Rep 39(2):1863–1868

    Article  PubMed  CAS  Google Scholar 

  5. Ergen A, Isbir S, Timirci O, Tekeli A, Isbir T (2011) Effects of myeloperoxidase −463 G/A gene polymorphism and plasma levels on coronary artery disease. Mol Biol Rep 38(2):887–891

    Article  PubMed  CAS  Google Scholar 

  6. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62:707–714

    Article  PubMed  CAS  Google Scholar 

  7. Tang NP, Wang LS, Yang L, Zhou B, Gu HJ, Sun QM, Cong RH, Zhu HJ, Wang B (2008) Protective effect of an endothelial lipase gene variant on coronary artery disease in a Chinese population. J Lipid Res 49:369–375

    Article  PubMed  CAS  Google Scholar 

  8. Shimizu M, Kanazawa K, Hirata K, Ishida T, Hiraoka E, Matsuda Y, Iwai C, Miyamoto Y, Hashimoto M, Kajiya T, Akita H, Yokoyama M (2007) Endothelial lipase gene polymorphism is associated with acute myocardial infarction, independently of high-density lipoprotein-cholesterol levels. Circ J 71:842–846

    Article  PubMed  CAS  Google Scholar 

  9. Vergeer M, Cohn DM, Boekholdt SM, Sandhu MS, Prins HM, Ricketts SL, Wareham NJ, Kastelein JJ, Khaw KT, Kamphuisen PW, Dallinga-Thie GM (2010) Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT. Atherosclerosis 211:558–564

    Article  PubMed  CAS  Google Scholar 

  10. Yamakawa-Kobayashi K, Yanagi H, Endo K, Arinami T, Hamaguchi H (2003) Relationship between serum HDL-C levels and common genetic variants of the endothelial lipase gene in Japanese school-aged children. Hum Genet 113:311–315

    Article  PubMed  CAS  Google Scholar 

  11. Hutter CM, Austin MA, Farin FM, Viernes HM, Edwards KL, Leonetti DL, McNeely MJ, Fujimoto WY (2006) Association of endothelial lipase gene (LIPG) haplotypes with high-density lipoprotein cholesterol subfractions and apolipoprotein AI plasma levels in Japanese Americans. Atherosclerosis 185:78–86

    Article  PubMed  CAS  Google Scholar 

  12. Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36:959–969

    Article  PubMed  CAS  Google Scholar 

  13. Kallner A, Estonius M (2006) Measurement of apolipoproteins is better than routinely measured traditional lipids. Lakartidningen 103(753–756):758

    Google Scholar 

  14. Goswami B, Rajappa M, Mallika V, Kumar S, Shukla DK (2008) Apo-B/apo-AI ratio: a better discriminator of coronary artery disease risk than other conventional lipid ratios in Indian patients with acute myocardial infarction. Acta Cardiol 63:749–755

    Article  PubMed  Google Scholar 

  15. Chien KL, Hsu HC, Su TC, Chen MF, Lee YT, Hu FB (2007) Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese. J Lipid Res 11:2499–2505

    Article  Google Scholar 

  16. McCy MG, Sun GS, Marchadier D, Maugeais C, Glick JM, Rader DJ (2002) Characterization of the lipolytic activity of endothelial lipase. J Lipid Res 43:921–929

    Google Scholar 

  17. Tanaka H, Ishida T, Johnston TP, Yasuda T, Ueyama T, Kojima Y, Kundu RK, Quertermous T, Ishikawa Y, Hirata K (2009) Role of endothelial lipase in plasma HDL levels in a murine model of hypertriglyceridmia. J Atheroscler Thromb 16:327–338

    Article  PubMed  CAS  Google Scholar 

  18. Ishida T, Choi S, Kundu RK, Hirata K, Rubin EM, Cooper AD, Quertermous T (2003) Endothelial lipase is a major determinant of HDL level. J Clin Invest 111:347–355

    PubMed  CAS  Google Scholar 

  19. Ma K, Cilingiroglu M, Otvos JD, Ballantyne CM, Marian AJ, Chan L (2003) Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism. Proc Natl Acad Sci USA 100:2748–2753

    Article  PubMed  CAS  Google Scholar 

  20. Hara T, Ishida T, Kojima Y, Tanaka H, Yasuda T, Shinohara M, Toh R, Hirata K (2011) Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo. J Lipid Res 52:57–67

    Article  PubMed  CAS  Google Scholar 

  21. Jin W, Millar JS, Broedl U, Glick JM, Rader DJ (2003) Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo. J Clin Invest 111:357–362

    PubMed  CAS  Google Scholar 

  22. Ishida T, Choi SY, Kundu RK, Spin J, Yamashita T, Hirata K, Kojima Y, Yokoyama M, Cooper AD, Quertermous T (2004) Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. J Biol Chem 279:45085–45092

    Article  PubMed  CAS  Google Scholar 

  23. Yasuda T, Hirata K, Ishida T, Kojima Y, Tanaka H, Okada T, Quertermous T, Yokoyama M (2007) Endothelial lipase is increased by inflammation and promotes LDL uptake in macrophages. J Atheroscler Thromb 14:192–201

    Article  PubMed  CAS  Google Scholar 

  24. Shiu SW, Tan KC, Huang Y, Wong Y (2008) Type 2 diabetes mellitus and endothelial lipase. Atherosclerosis 198:441–447

    Article  PubMed  CAS  Google Scholar 

  25. Badellino KO, Wolfe ML, Reilly MP, Rader DJ (2006) Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med 3:e22

    Article  PubMed  Google Scholar 

  26. Fang YQ, Huang L, Li AM, Song YM, Jin J, Geng ZH, Yu XJ, Deng MY (2007) Significance of the ratio of circulating endothelial cell expressing endothelial lipase and supersensitivity C-reactive protein in prognosis of patients with coronary artery disease. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue (Chin) 19:644–646

    CAS  Google Scholar 

  27. deLemos AS, Wolfe ML, Long CJ, Sivapackianathan R, Rader DJ (2002) Identification of genetic variants in endothelial lipase in persons with elevated high-density lipoprotein cholesterol. Circulation 106:1321–1326

    Article  PubMed  CAS  Google Scholar 

  28. Edmondson AC, Brown RJ, Kathiresan S, Cupples LA, Demissie S, Manning AK, Jensen MK, Rimm EB, Wang J, Rodrigues A, Bamba V, Khetarpal SA, Wolfe ML, Derohannessian S, Li M, Reilly MP, Aberle J, Evans D, Hegele RA, Rader DJ (2009) Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J Clin Invest 119:1042–1050

    PubMed  CAS  Google Scholar 

  29. Liu WY, Yin RX, Zhang L, Cao XL, Miao L, Wu DF, Aung LH, Hu XJ, Lin WX, Yang DZ (2010) Association of the LIPG 584C > T polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations. Lipids Health Dis 9:110

    Article  PubMed  Google Scholar 

  30. Durlach V, Durlach A, Movesayan I, Socquard E, Zellner C, Clavel C, Nazeyrollas P, Malloy MJ, Pullinger CR, Kane JP, Ducasse A, Aouizerat BE (2011) Association of endothelial lipase Thr111Ile polymorphism with lipid metabolism and microvascular complications in type 2 diabetic patients. Diabetes Metab 37:64–71

    Article  PubMed  CAS  Google Scholar 

  31. Jensenm MK, Rimm EB, Mukamal KJ, Edmondson AC, Raderm DJ, Vogel U, Tjonneland A, Sorensen TI, Schmidt EB, Overvad K (2009) The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations. Eur Heart J 30:1584–1589

    Article  Google Scholar 

  32. Huang Y, Bai H, Fan P, Liu R, Liu Y, Liu BW (2008) The −384A > C polymorphism of endothelial lipase gene promoter region in Chinese healthy normolipidemic and endogenous hypertriglyceridemic subjects. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (Chin) 25:443–446

    CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the Science and technology project of Wujin (WS2010010). The authors are grateful to the staff of the department of Cardiology, Wujin Hospital for their facilitation in the sample collection.

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gaojun Cai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cai, G., He, G. & Qi, C. The association between endothelial lipase −384A/C gene polymorphism and acute coronary syndrome in a Chinese population. Mol Biol Rep 39, 9879–9884 (2012). https://doi.org/10.1007/s11033-012-1854-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-1854-y

Keywords

Navigation